EUVIMEDEUVIMED entdecken
Open Access

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke

MARVEL Trial Authors for the MARVEL Investigators, Qingwu Yang, Changwei Guo, Chengsong Yue, Jiaxing Song, Jie Yang, Zhouzhou Peng, Nizhen Yu, Jiacheng Huang, Linyu Li, Jiandi Huang, Yifei Chen und 48 weitere

JAMA · 12.03.2024 · 331 (10) · 840

DOI: 10.1001/jama.2024.0626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 12.03.2024. Verfasst von MARVEL Trial Authors for the MARVEL Investigators und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing,…. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance It is uncertain whether intravenous methylprednisolone improves outcomes for patients with acute ischemic stroke due to large-vessel occlusion (LVO) undergoing endovascular thrombectomy.

Objective

To assess the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO. Design, Setting, and Participants This investigator-initiated, randomized, double-blind, placebo-controlled trial was implemented at 82 hospitals in China, enrolling 1680 patients with stroke and proximal intracranial LVO presenting within 24 hours of time last known to be well. Recruitment took place between February 9, 2022, and June 30, 2023, with a final follow-up on September 30, 2023.

Interventions

Eligible patients were randomly assigned to intravenous methylprednisolone (n = 839) at 2 mg/kg/d or placebo (n = 841) for 3 days adjunctive to endovascular thrombectomy. Main Outcomes and Measures The primary efficacy outcome was disability level at 90 days as measured by the overall distribution of the modified Rankin Scale scores (range, 0 [no symptoms] to 6 [death]). The primary safety outcomes included mortality at 90 days and the incidence of symptomatic intracranial hemorrhage within 48 hours.

Results

Among 1680 patients randomized (median age, 69 years; 727 female [43.3%]), 1673 (99.6%) completed the trial. The median 90-day modified Rankin Scale score was 3 (IQR, 1-5) in the methylprednisolone group vs 3 (IQR, 1-6) in the placebo group (adjusted generalized odds ratio for a lower level of disability, 1.10 [95% CI, 0.96-1.25]; P = .17). In the methylprednisolone group, there was a lower mortality rate (23.2% vs 28.5%; adjusted risk ratio, 0.84 [95% CI, 0.71-0.98]; P = .03) and a lower rate of symptomatic intracranial hemorrhage (8.6% vs 11.7%; adjusted risk ratio, 0.74 [95% CI, 0.55-0.99]; P = .04) compared with placebo. Conclusions and Relevance Among patients with acute ischemic stroke due to LVO undergoing endovascular thrombectomy, adjunctive methylprednisolone added to endovascular thrombectomy did not significantly improve the degree of overall disability. Trial Registration ChiCTR.org.cn Identifier: ChiCTR2100051729

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeStrokeFemaleHumansAgedDouble-Blind MethodThrombectomyIntracranial HemorrhagesMethylprednisolone

Substanzen

Methylprednisolone

Autor:innen und Institutionen

  • Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Department of Neurology, Qujing No. 1 Hospital Affiliated Hospital of Kunming Medical University, Qujing, China.
  • Department of Neurology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
  • Department of Neurology, Jingdezhen No. 1 People's Hospital, Jingdezhen, China.
  • Department of Neurology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Department of Neurology, Jiangmen Central Hospital, Jiangmen, China.

Zitieren

APA

MARVEL Trial Authors for the MARVEL Investigators, Yang, Q., Guo, C., Yue, C., Song, J., Yang, J., Peng, Z., Yu, N., Huang, J., Li, L., Huang, J., Chen, Y., Zheng, C., Jiang, S., Ruan, Z., Zhang, M., Song, D., Luo, X., Tian, Y., …, & Fan, S. (2024). Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke. JAMA, 331(10), 840. https://doi.org/10.1001/jama.2024.0626

Vancouver

MARVEL Trial Authors for the MARVEL Investigators, Yang Q, Guo C, Yue C, Song J, Yang J, et al. Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke. JAMA. 2024;331(10):840. doi:10.1001/jama.2024.0626

BibTeX
@article{MARVELTrialAuthorsfortheMARVELInvestigators2024,
  author = {MARVEL Trial Authors for the MARVEL Investigators, MARVEL Trial Authors for the MARVEL Investigators and Yang, Qingwu and Guo, Changwei and Yue, Chengsong and Song, Jiaxing and Yang, Jie and Peng, Zhouzhou and Yu, Nizhen and Huang, Jiacheng and Li, Linyu and Huang, Jiandi and Chen, Yifei and Zheng, Chong and Jiang, Shunfu and Ruan, Zhongfan and Zhang, Min and Song, Dengwen and Luo, Xiaojun and Tian, Yaoyu and Yang, Mei and Deng, Shenglin and Wei, Shirong and Wu, Youlin and Tang, Yufeng and Yang, De and Tan, Xiaolin and Zeng, Guoyong and Cheng, Daoyou and Liu, Wenhua and He, Wencheng and Cai, Tieying and Pan, Chengde and Liao, Jiasheng and Lei, Bo and Pu, Shengxiong and Jin, Zhenglong and Li, Jinglun and Xia, Zhongbin and Zhang, Guling and Luo, Jun and Sun, Yaxuan and Xiong, Xiaoping and Wang, Jian and Li, Bo and Peng, Yuqi and Chen, Kechun and Shan, Yuanjun and Zhou, Peiyang and Huang, Xinyuan and Luo, Shiwei and Zhang, Jie and Liu, Chang and Jiang, Lin and Yang, Dahong and Tian, Yan and Hu, Jinrong and Qiu, Zhongming and Ma, Jinfu and Xu, Xu and Fan, Shitao},
  title = {Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {10},
  pages = {840},
  doi = {10.1001/jama.2024.0626}
}
Kostenlos starten →